a probable point of origin ( Figure 1 ). The concept has been around for some time, but making it work is another matter. The calcified shells laid down by larval bivalves include trace elements deposited in ratios that reflect the water masses where they developed [12] . If there are sufficient differences in the elemental signatures of sites, then larval shells are effectively tagged by their point or origin. With this approach, Carson et al. [1] examine larval exchange for two co-occurring mussel species in California over two years, matching this with field measurements of water currents. The two species overlap in their distribution and their larvae disperse in the same largely passive way, moving in similar directions at similar speeds. However, and this is critical, the two species breed at different times. The consequence is enormous because local currents show strong seasonality (to the north in autumn and to the south in spring). Therefore, their populations show completely different connectivity and completely different source-sink dynamics: one species shows peak breeding in autumn, with southern populations acting as larval sources and northern sites as sinks. The other species breeds mainly in spring and shows exactly the reverse pattern.
Benthic animals like mussels are heavily overexploited as food in many parts of the world and the commonest management tool is the Marine Protected Area which should act as a supply point, providing spill-over of larvae to exploited populations. Unfortunately, these findings make the design of marine protected areas more difficult by clearly showing that we cannot make assumptions about connectivity by extrapolating from one target species to others. Simply, a marine protected area may function excellently for one species, but not others that co-occur with it. The best hope is to design reserves around the needs of a foundation species that provides a habitat for many others, such as mussels (Figure 1 ), but as Carson et al. [1] show, even this is complicated by subtle differences in basic biology.
Perhaps most critically, Carson et al. [1] point out that the timing of reproduction responds to abrupt changes in seawater temperature and phytoplankton availability. The timing of both is likely to differ from year to year, and indeed to change over longer time periods in response to systematic changes in global climate. Whatever scale you look at, timing is everything. 4 volume-regulated anion channels, plasma membrane variants of the mitochondrial voltage-dependent anion-selective channel (VDAC), porins, and maxianion channels [1] . Additionally, hemichannels composed of protein subunits from the connexin or the pannexin family have been reported to be involved [2] . A recent report in Nature by Chekeni et al. [3] now sheds more light on the mechanisms underlying nucleotide release in the very special context of apoptosis. After their previous work showing that extracellular ATP and UTP can function as apoptotic 'find-me' signals for the recruitment of monocytes [4] , the group of Kodi Ravichandran has now addressed the question of how these nucleotides are liberated during apoptosis and has identified the plasma membrane channel pannexin 1 (Panx1) as a key player in this context. Panx1 belongs to a family of three membrane proteins (Panx1, 2, and 3) that exhibit similar topology (Figure 1 ) but minor sequence homology to the larger family of connexins. In contrast to Panx2, which is restricted to the brain, and Panx3, which is predominantly a skin and connective tissue gene product, Panx1 is widely expressed in diverse tissues [5] . It forms large pore channels that allow the passage of anionic and cationic molecules smaller than w1 kDa, including ions, amino acids, and nucleotides, between the cytoplasm and the extracellular space [6] . The role of Panx1 as an ATP channel has been studied in a broad range of tissues and physiological responses. As such, it has been implicated in ATP release during the activation of macrophages and T lymphocytes [7] , shear or hypotonic stress responses in erythrocytes as well as airway epithelia [8, 9] , and the propagation of intercellular Ca 2+ waves along astrocytes [10] .
The study by Chekeni et al. Conversely, Panx1 overexpression resulted in enhanced nucleotide release during apoptosis and was paralleled by increased monocyte migration towards the corresponding culture supernatants. Whole-cell patch-clamp analyses revealed Panx1-mediated currents only in apoptosing but not viable cells, suggesting the specific opening of the Panx1 channel during the course of apoptosis. Dye-uptake assays using Panx1-silenced or Panx1-overexpressing cells as well as carbenoxolone further confirmed this notion. Hence, opening of Panx1 channels appears to be a crucial prerequisite for apoptotic nucleotide release -at least in T cells, since Chekeni et al. [3] used Jurkat T lymphoma cells and primary thymocytes for their study.
The question that arises is whether Panx1-mediated nucleotide liberation is a general apoptotic phenomenon that takes place in other cell types as well. If so, it might overlap or interfere with other Panx1/ATP-governed processes. This is of special interest in the brain, where Panx1-mediated ATP secretion is known to contribute to the propagation of intercellular Ca 2+ waves with implications for 'short circuits' in terms of epileptiformic seizures [11] . Additionally, in cells with a functional inflammasome machinery -the high molecular weight complex involved in pro-interleukin-1b (pro-IL-1b) and pro-interleukin-18 (pro-IL-18) maturation -Panx1 channel opening has been shown to contribute to the processing and the release of IL-1b and IL-18 and subsequent immune cell activation [7, 12] . If these pro-inflammatory cytokines were also liberated during the course of apoptosis, this would somehow challenge the current concept that apoptosis is an immunologically silent, anti-inflammatory form of cell death [13] .
Another issue being raised by the work of Chekeni et al. [3] is the selectivity of the Panx1 pore. In their initial report the authors emphasized that equimolar amounts of ATP and UTP were secreted during apoptosis [4] . Given that the intracellular ATP concentration far exceeds that of UTP, this either reflects the consumption of ATP during apoptosis or the existence of mechanisms favoring the selective export of UTP. Is Panx1 involved in this discrimination process? If so, what are the underlying mechanisms? So far, the Panx1 pore has been described to be rather unselective and to allow the passage of a broad range of small anions as well as cations of up to 1 kDa in size, including metal ions, amino acids, prostaglandins, and nucleotides [6] . This opens up the possibility that Panx1 might also be involved in the release of other low molecular 'find-me' signals, such as sphingosine-1-phosphate and lysophosphatidylcholine, whose export mechanisms to date remain elusive [14] [15] [16] . However, given this degree of unselective permeability, other low molecular weight compounds, including the prototypical danger signal uric acid [17] , are likely to 'escape' as well, rendering Panx1 opening during apoptosis comparable to opening Pandora's box in the Greek myth. Conceivably, additional mechanisms might fine-tune the permeability of Panx1 during apoptosis. One such putative mechanism could be implied in the very special mode of apoptosis-associated Panx1 activation. So far, Panx1 hemichannels have been demonstrated to be activated by diverse experimental conditions, including mechanical/ osmotic stress, strong membrane depolarizations, and activation of purinergic receptors, such as P2Y 1 R, P2Y 2 R, and P2X 7 R, by ATP and other agonists [18] . Chekeni et al. [3] now have identified caspase-3/7-mediated cleavage within the intracellular carboxy-terminal region to be essential for Panx1 gating during apoptosis. Transfection with a cleavage-site mutant resulted in reduced dye uptake, abolished carbenoxolone-sensitive current density, and importantly blocked ATP release during apoptosis, implying a dominant-negative effect of the ectopic mutant on the endogenous wild-type Panx1. On the contrary, overexpression of a form of Panx1 truncated at the putative caspase cleavage site led to constitutive dye uptake and carbenoxolone-sensitive currents in viable, non-apoptosing cells. This suggests that Panx1 cleavage is sufficient for Panx1 opening and should result in nucleotide release and consequently also monocyte recruitment by viable cells. Unfortunately, this crucial question remains open. Nevertheless, cleavage-mediated Panx1 gating during apoptosis is an intriguing, novel finding, and future studies are required to address the remaining questions regarding the effect of proteolytic processing on Panx1 activity: is this activation of Panx1 a result of the removal of an auto-inhibitory domain located in the carboxyl terminus? Does the carboxyl terminus carry sites of post-translational modification (e.g. phosphorylation) that govern Panx1 opening, or does it harbor binding sites for negative regulatory proteins? One such negative regulator could be the purinergic receptor P2X 7 R, whose physical interaction accompanied by a negative regulatory effect on Panx1 has already been described [12] .
The study by Chekeni et al. [3] reveals interesting and novel aspects of nucleotide release in the context of phagocyte recruitment during apoptosis, and it will be tantalizing to examine the relevance of the Panx1-nucleotide axis in vivo. In particular, exploring the phenotype of the Panx1 knock-out mouse [19] , for instance in the context of glucocorticoid-induced thymus atrophy, a model that has already been successfully used by the Ravichandran group [4] , might extend the current knowledge of apoptotic cell clearance and its implications for chronic inflammatory and autoimmune disorders [13] . Hence, the report by Chekeni et al. [3] not only allows us deeper insight into the signaling mechanisms between dying cells and professional phagocytes but also fuels our hope -the last gift escaping from Pandora's box -for the translation of these findings into future therapeutic approaches targeting chronic inflammation, autoimmunity, and tumor vaccination.
